BridgeMD
New treatment option for Plantar Fasciitis, Chronic
Official title Sensitivity and Tests for Evaluation of Plantar Fasciopathy
ClinicalTrials.gov ID: NCT07567807
What this study is testing
- What it's testing
- Plantar fasciopathy (PF), one of the leading causes of foot pain, affects up to one in ten individuals in their lifetime. Characterized by pain and structural alterations at the proximal insertion of the plantar fascia on the calcaneus, the term "PF" has replaced "plantar fasciitis," as degenerative tissue changes predominate over inflammatory processes.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 18. Healthy volunteers may be eligible.
You may be able to join if
- PF group:
- Patients on the waiting list at Clinic I of the Rizzoli Orthopaedic Institute for surgical intervention with a diagnosis of recalcitrant PF lasting...
- Age \>18 years
- MRI of the foot and ankle negative for other local causes of pain included in the differential diagnosis of PF
- Negative electromyography for tarsal tunnel syndrome
You likely can't join if
- PF and control groups:
- Minor patients
- Patients with diagnosed rheumatologic diseases currently under pharmacological treatment
- Patients with diabetes or diabetic neuropathy
- Pregnant women
See the full eligibility criteria
- PF group:
- Patients on the waiting list at Clinic I of the Rizzoli Orthopaedic Institute for surgical intervention with a diagnosis of recalcitrant PF lasting at least 12 months
- Age \>18 years
- MRI of the foot and ankle negative for other local causes of pain included in the differential diagnosis of PF
- Negative electromyography for tarsal tunnel syndrome
- Control group:
- Age \>18 years
- Outpatients followed at Clinic I for conditions unrelated to the foot and ankle, with no clinical history of foot pain or pathology in the preceding 12 months
- PF and control groups:
- Minor patients
- Patients with diagnosed rheumatologic diseases currently under pharmacological treatment
- Patients with diabetes or diabetic neuropathy
- Pregnant women
The study team makes the final eligibility decision.
Where it's taking place
- Bologna, BO, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bologna, BO, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.